Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Karagiannis, A., & Harsoulis F. (2005).  Gonadal dysfunction in systemic diseases.. Eur J Endocrinol. 152(4), 501-13.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., & Harsoulis F. (2007).  Pheochromocytoma: an update on genetics and management.. Endocr Relat Cancer. 14(4), 935-56.
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy. Core Evidence. Volume 12, 1 - 10.
Karagiannis, A., Tziomalos K., Pagourelias E. D., Gossios T. D., & Athyros V. G. (2010).  Effect of antihypertensive drug-associated diabetes on cardiovascular risk.. Hellenic J Cardiol. 51(3), 195-9.
Karagiannis, T., Boura P., & Tsapas A. (2014).  Safety of dipeptidyl peptidase 4 inhibitors: a perspective review.. Ther Adv Drug Saf. 5(3), 138-46.
Karagiannis, T., Tsapas A., Bekiari E., Toulis K. A., & Nauck M. A. (2024).  A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.. Diabetes Care. 47(2), 184-192.
Karagiannis, A., Skolarikos A., Alexandrescu E., Basic D., Geavlete P., Maletta A., et al. (2017).  Epidemiologic study of urolithiasis in seven countries of South-Eastern Europe: S.E.G.U.R. 1 study.. Arch Ital Urol Androl. 89(3), 173-177.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.. Ther Adv Drug Saf. 7(2), 36-8.
Karagiannis, T., Liakos A., Bekiari E., Athanasiadou E., Paschos P., Vasilakou D., et al. (2015).  Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.. Diabetes Obes Metab. 17(11), 1065-74.
Karagiannis, A., Tziomalos K., Kakafika A., Harsoulis F., & Zamboulis C. (2004).  Paralysis as first manifestation of primary aldosteronism.. Nephrol Dial Transplant. 19(9), 2418-9.
Karagiannidou, E. G., Bekiari E. T., & Vastardi E. I. (2015).  A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.. J Chromatogr Sci. 53(8), 1296-302.
Karagiannidis, E., Sofidis G., Stalikas N., Kartas A., Kangelidis I., Barmpas A., et al. (2020).  Rationale and design of a prospective, single-arm trial for the evaluation of safety and feasibility of large thrombus burden aspiration in the context of ST elevation myocardial infarction.. Hellenic J Cardiol.
Karagianni, P., Zampeli E., & Moutsopoulos H. M. (2018).  Evolution from one autoimmune disorder to another. Epitope spreading?. Scand J Immunol. 87(5), e12657.
Karagianni, P., Rallis D., Fidani L., Porpodi M., Kalinderi K., Tsakalidis C., et al. (2013).  Glutathion-S-Transferase P1 polymorphisms association with broncopulmonary dysplasia in preterm infants.. Hippokratia. 17(4), 363-7.
Karagianni, P., Briana D. D., Mitsiakos G., Elias A., Theodoridis T., Chatziioannidis E., et al. (2010).  Early versus delayed minimal enteral feeding and risk for necrotizing enterocolitis in preterm growth-restricted infants with abnormal antenatal Doppler results.. Am J Perinatol. 27(5), 367-73.
Karagianni, P., Tsakalidis C., Kyriakidou M., Mitsiakos G., Chatziioanidis H., Porpodi M., et al. (2011).  Neuromotor outcomes in infants with bronchopulmonary dysplasia.. Pediatr Neurol. 44(1), 40-6.
Karagianni, P., Lambropoulos V., Stergidou D., Fryssira H., Chatziioannidis I., & Spyridakis I. (2016).  Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited.. Am J Med Genet A. 170A(5), 1333-8.
Karagianni, P., Rallis D., Kyriakidou M., Tsakalidis C., Pratsiou P., & Nikolaidis N. (2014).  Correlation of brain ultrasonography scans to the neuromotor outcome of very-low-birth-weight infants during the first year of life.. J Child Neurol. 29(11), 1429-35.
Karagianni, P., Polyzos S. A., Bougiouklis D., Tsapas A., & Paletas K. (2015).  Investigating the role of Natural Killer T-cells in Gram negative infections of patients with type 2 diabetes mellitus.. Hippokratia. 19(3), 231-4.
Karagianni, P., Polyzos S. A., Kartali N., Zografou I., & Sambanis C. (2013).  Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapy.. Adv Med Sci. 58(1), 38-43.
Karagianni, P., Kyriakidou M., Mitsiakos G., Chatzioanidis H., Koumbaras E., Evangeliou A., et al. (2010).  Neurological outcome in preterm small for gestational age infants compared to appropriate for gestational age preterm at the age of 18 months: a prospective study.. J Child Neurol. 25(2), 165-70.
Karagianni, P., Sampanis C., Katsoulis C., Miserlis G., Polyzos S., Zografou I., et al. (2009).  Continuous subcutaneous insulin infusion versus multiple daily injections.. Hippokratia. 13(2), 93-6.
Karagergou, E., Papas A., Foroglou P., & Demiri E. (2012).  Management of the complications of tissue expansion during a 5-year period (2005-2010).. J Plast Surg Hand Surg. 46(3-4), 167-71.
Karagergou, E., Dionyssopoulos A., Karayannopoulou M., Psalla D., Theodoridis A., Demiri E., et al. (2018).  Adipose-derived stromal vascular fraction aids epithelialisation and angiogenesis in an animal model.. J Wound Care. 27(10), 637-644.
Karageorgou, D., Magriplis E., Mitsopoulou A. V., Dimakopoulos I., Bakogianni I., Micha R., et al. (2019).  Dietary patterns and lifestyle characteristics in adults: results from the Hellenic National Nutrition and Health Survey (HNNHS).. Public Health. 171, 76-88.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.